Sartorius AG SARTORIUS PREF SHS
Sartorius AG SARTORIUS PREF SHS/ DE0007165631 /
0NIR
24/05/2024 18:35:16
|
Chg.
-
|
Volume |
Bid17:40:08 |
Demandez à17:40:08 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
254.45EUR
|
-
|
11,663 Chiffrre d'affaires: 2.46 Mio. |
-Bid taille: - |
-Ask la taille: - |
13.3 Mrd.EUR |
0.34% |
71.77 |
Description de l'entreprise
The Sartorius Group is a leading international pharmaceutical and laboratory equipment provider with two divisions: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions with its broad product portfolio focusing on single-use solutions helps customers produce biotech medications and vaccines safely and efficiently. Lab Products & Services, with its premium laboratory instruments, consumables and services, concentrates on serving the needs of laboratories performing research and quality assurance at pharma and biopharma companies and on those of academic research institutes.
Conseil d'administration & Conseil de surveillance
PDG |
Joachim Kreuzburg |
Conseil d'administration |
Rainer Lehmann, Dr. René Fáber, Gerry MacKay, Alexandra Gatzemeyer |
Conseil de surveillance |
Dr. Lothar Kappich, Manfred Zaffke, Prof. David Raymond Ebsworth, Dr. Daniela Favoccia, Petra Kirchhoff, Dietmar Müller, Ilke Hildegard Panzer, Frank Riemensperger, Hermann Jens Ritzau, Prof. Dr. Klaus Rüdiger Trützschler, Sabrina Wirth |
Données de l'entreprise
Nom: |
Sartorius AG |
Adresse: |
Otto-Brenner-Str. 20,D-37079 Goettingen |
Téléphone: |
+49-551-308-0 |
Fax: |
+49-551-308-3289 |
Courriel: |
info@sartorius.com
|
Internet: |
www.sartorius.de |
Industrie: |
Technology |
Secteur: |
Other Technology Industries |
Sous-secteur: |
- |
Fin de l'exercice financier: |
31/12 |
Flotte libre: |
40.81% |
IPO date: |
10/07/1990 |
Principaux actionnaires
FreeFloat |
|
72.00% |
Bio-Rad Laboratories |
|
28.00% |